Revista da Associacao Medica Brasileira (1992)
-
Rev Assoc Med Bras (1992) · Jan 2023
Turkish validity and reliability of the lifestyle questionnaire related to cancer.
The aim of this study was to adapt the lifestyle questionnaire related to cancer in Turkish and investigate its validity and reliability. ⋯ The Turkish version of lifestyle questionnaire related to cancer (8 subscales, 41 items) is a reliable and valid measure to evaluate lifestyle behaviors related to cancer in adults.
-
Rev Assoc Med Bras (1992) · Jan 2023
Relationship of irisin expression with metabolic alterations and cardiovascular risk in type 2 diabetes mellitus: a preliminary study.
The aim of this study was to investigate the role of irisin in type 2 diabetes mellitus and its association with metabolic alterations and obesity. ⋯ The data suggests that body mass index directly influences plasma irisin levels and the regulation of irisin gene expression, possibly linking irisin to adiposity changes observed in obesity-related type 2 diabetes mellitus.
-
Rev Assoc Med Bras (1992) · Jan 2023
Urbanization and kidney dysfunction in Brazilian indigenous people: a burden for the youth.
The aim of this study was to investigate whether the degree of urbanization influences the prevalence of chronic kidney disease in Brazilian indigenous people. ⋯ Our results suggest that a higher degree of urbanization seems to negatively influence the prevalence of chronic kidney disease in Brazilian indigenous people.
-
This study aimed to describe the current situation of sexual aggression and assess the adhesion to ambulatory care follow-up. ⋯ Black girls, especially those aged <14 years, are in a situation of greater vulnerability for sexual violence, have less adhesion to follow-up, and often experience aggression in the household setting.
-
Rev Assoc Med Bras (1992) · Jan 2023
Neuropathy in multiple sclerosis patients treated with teriflunomide.
Teriflunomide is an oral medication approved for the treatment of patients with multiple sclerosis. The primary effect of teriflunomide is to reduce de novo pyrimidine synthesis by inhibiting mitochondrial dihydroorotate dehydrogenase, thereby causing cell-cycle arrest. We aimed to investigate the occurrence of peripheral neuropathy, a rare side effect of teriflunomide, in patients receiving teriflunomide. ⋯ Teriflunomide has the potential to cause peripheral neuropathy. The awareness of peripheral neuropathy, questioning the symptoms, and if suspected, evaluation with electromyography and switching the therapy in patients under teriflunomide treatment are crucial.